α7-Containing and non-α7-containing nicotinic receptors respond differently to spillover of acetylcholine

J Neurosci. 2011 Oct 19;31(42):14920-30. doi: 10.1523/JNEUROSCI.3400-11.2011.

Abstract

We explored whether nicotinic acetylcholine receptors (nAChRs) might participate in paracrine transmission by asking if they respond to spillover of ACh at a model synapse in the chick ciliary ganglion, where ACh activates diffusely distributed α7- and α3-containing nAChRs (α7-nAChRs and α3*-nAChRs). Elevating quantal content lengthened EPSC decay time and prolonged both the fast (α7-nAChR-mediated) and slow (α3*-nAChR-mediated) components of decay, even in the presence of acetylcholinesterase. Increasing quantal content also prolonged decay times of pharmacologically isolated α7-nAChR- and α3*-nAChR-EPSCs. The effect upon EPSC decay time of changing quantal content was 5-10 times more pronounced for α3*-nAChR- than α7-nAChR-mediated currents and operated over a considerably longer time window: ≈ 20 vs ≈ 2 ms. Control experiments rule out a presynaptic source for the effect. We suggest that α3*-nAChR currents are prolonged at higher quantal content because of ACh spillover and postsynaptic potentiation (Hartzell et al., 1975), while α7-nAChR currents are prolonged probably for other reasons, e.g., increased occupancy of long channel open states. α3*-nAChRs report more spillover when α7-nAChRs are competitively blocked than under native conditions; this could be explained if α7-nAChRs buffer ACh and regulate its availability to activate α3*-nAChRs. Our results suggest that non-α7-nAChRs such as α3*-nAChRs may be suitable for paracrine nicotinic signaling but that α7-nAChRs may not be suitable. Our results further suggest that α7-nAChRs may buffer ACh and regulate its bioavailability.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetylcholine / metabolism*
  • Acetylcholine / pharmacology
  • Aconitine / analogs & derivatives
  • Aconitine / pharmacology
  • Anesthetics, Local / pharmacology
  • Animals
  • Biophysical Phenomena / drug effects
  • Biophysical Phenomena / genetics
  • Cadmium Chloride / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Chick Embryo
  • Cholinesterase Inhibitors / pharmacology
  • Conotoxins / pharmacology
  • Echothiophate Iodide / pharmacology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / genetics
  • Female
  • Ganglia, Parasympathetic / cytology
  • Lidocaine / analogs & derivatives
  • Lidocaine / pharmacology
  • Male
  • Models, Biological
  • Neurons / drug effects
  • Neurons / metabolism*
  • Nicotinic Antagonists / pharmacology
  • Patch-Clamp Techniques / methods
  • Protein Subunits / genetics
  • Protein Subunits / metabolism*
  • Receptors, Nicotinic / genetics
  • Receptors, Nicotinic / metabolism*
  • Time Factors
  • omega-Conotoxin GVIA / pharmacology

Substances

  • Anesthetics, Local
  • Calcium Channel Blockers
  • Cholinesterase Inhibitors
  • Conotoxins
  • Nicotinic Antagonists
  • Protein Subunits
  • Receptors, Nicotinic
  • alpha-conotoxin MII
  • methyllycaconitine
  • QX-314
  • omega-Conotoxin GVIA
  • Lidocaine
  • Echothiophate Iodide
  • Cadmium Chloride
  • Acetylcholine
  • Aconitine